✦ LIBER ✦

A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease

✍ Scribed by Stefan Schreiber; Paul Rutgeerts; Richard N. Fedorak; Munaa Khaliq–Kareemi; Michael A. Kamm; Michel Boivin; Charles N. Bernstein; Michael Staun; Ole Østergaard Thomsen; Alison Innes

Book ID: 119758691
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 228 KB
Volume: 129
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2005.06.064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Certolizumab Pegol (CDP870) for Treatmen

Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease

✍ Guy Sisson; Adam Harris 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Certolizumab Pegol for the Treatment of

Certolizumab Pegol for the Treatment of Crohn's Disease

✍ Sandborn, William J.; Feagan, Brian G.; Stoinov, Simeon; Honiball, Pieter J.; Ru 📂 Article 📅 2007 🏛 Massachusetts Medical Society 🌐 English ⚖ 224 KB

Certolizumab pegol a PRECiSE treatment f

Certolizumab pegol a PRECiSE treatment for Crohn's disease

✍ Crofskey, S 📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 198 KB

Randomised clinical trial: certolizumab

Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease – subgroup results from a placebo-controlled study

✍ S. Schreiber; I. C. Lawrance; O. Ø. Thomsen; S. B. Hanauer; R. Bloomfield; W. J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Certolizumab pegol a sure contender for

Certolizumab pegol a sure contender for Crohn's disease

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Adalimumab and Certolizumab Pegol for th

Adalimumab and Certolizumab Pegol for the Treatment of Crohn's Disease: Does BMI Make a Difference?

✍ Moore, John M. ;Beaulieu, Dawn B. ;Horst, Sara N. ;Armstrong, Sharelle ;Duncan, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 90 KB